Q&A: Market access strategies for innovative drugs

Date

06.10.20

Time

14:00 - 15:00

Location

Online
Share event

Over the last two decades, biopharmaceutical manufacturers have faced new obstacles in the market access of their products. The increasing development costs, shifting influences between stakeholders, and growing pharmaceutical competition are just some of the factors that are reshaping pharma’s market access. In an increasingly cost-conscious healthcare environment, pharma companies must make a thorough case for not only the clinical, but also the economic value of their products.

This webinar will have expert speakers sharing their perspectives on the dynamics and challenges of market access for innovative biopharmaceutical products.

Topics:

  • Market access as a key enabler for commercial success
  • How to manage market access for products in early development
  • Factors influencing price and reimbursement/funding for biopharma products
  • Gaining market access in a challenging European environment

Moderator:

Leonildo Delgado, Manager Innovation